Abstract
Regulatory T (Treg) cells that express the transcription factor Foxp3 are essential for maintaining tolerance at mucosal interfaces, where they act by controlling inflammation and promoting epithelial cell homeostasis. There are two major regulatory T-cell subsets, “natural” CD4+ Treg (nTreg) cells that develop in the thymus and “induced” Treg (iTreg) cells that develop from conventional CD4+ T (Tconv) cells in the periphery. Dysregulated Treg cell responses are associated with autoimmune diseases, including inflammatory bowel disease (IBD) and arthritis. Adoptive transfer of Treg cells can modulate innate and adaptive immune responses and cure disease in animal models, which has generated considerable interest in using Treg cells to treat human autoimmune disease, prevent rejection of transplanted organs, and to control graft-versus-host disease following hematopoietic stem cell transplantation. Herein, we describe our modifications of a treatment model of T-cell transfer colitis designed to allow mechanistic investigation of the two major Treg cell subsets and to compare their specific roles in mucosal tolerance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531–564
Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ (2001) Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301–306
Relland LM, Mishra MK, Haribhai D, Edwards B, Ziegelbauer J, Williams CB (2009) Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression. J Immunol 182:1341–1350
Schmitt EG, Williams CB (2013) Generation and function of induced regulatory T cells. Front Immunol 4:152
Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150:29–38
Haribhai D, Lin W, Edwards B, Ziegelbauer J et al (2009) A central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol 182:3461–3468
Haribhai D, Williams JB, Jia S, Nickerson D et al (2011) A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35:109–122
Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, Umetsu DT, Rudensky AY (2012) Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482:395–399
Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106:R75–R81
Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B et al (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68–73
Bennett CL, Christie J, Ramsdell F, Brunkow ME et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21
Wildin R, Ramsdell S, Peake FJ, Faravelli F et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18–20
Chatila TA (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949–959
Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115:1923–1933
Thorstenson KM, Khoruts A (2001) Generation of anergic and potentially immunoregulatory CD25+ CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 167:188–195
Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401–1408
Mucida D, Pino-Lagos K, Kim G, Nowak E, Benson MJ, Kronenberg M, Noelle RJ, Cheroutre H (2009) Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30:471–472
Quintana FJ, Basso AS, Iglesias AH, Korn T et al (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65–71
Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107:12204–12209
Schmitt E, Haribhai GD, Williams JB, Aggarwal P et al (2012) IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy. J Immunol 189:5638–5648
Relland LM, Williams JB, Relland GN, Haribhai D, Ziegelbauer J, Yassai M, Gorski J, Williams CB (2012) The TCR repertoires of regulatory and conventional T cells specific for the same foreign antigen are distinct. J Immunol 189:3566–3574
Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ (2008) Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29:114–126
Curotto de Lafaille MA, Lafaille JJ (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30:626–635
Trzonkowski P, Bieniaszewska M, Juscinska J, Dobyszuk A, Krzystyniak A, Marek N, Mysliwska J, Hellmann A (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+ CD127− T regulatory cells. Clin Immunol 133:22–26
Trzonkowski P, Szarynska M, Mysliwska J, Mysliwski A (2009) Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy. Cytometry A 75:175–188
Brunstein CG, Miller JS, Cao Q, McKenna DH et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117:1061–1070
Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463:808–812
Floess S, Freyer J, Siewert C, Baron U et al (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5:e38
Polansky JK, Kretschmer K, Freyer J, Floess S (2008) DNA methylation controls Foxp3 gene expression. Eur J Immunol 38:1654–1663
Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995–1004
Uhlig HH, Coombes J, Mottet C, Izcue A et al (2006) Characterization of Foxp3+ CD4+ CD25+ and IL-10-secreting CD4+ CD25+ T cells during cure of colitis. J Immunol 177:5852–5860
Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA (2007) Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol 178:2961–2972
Lin W, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, Chatila TA (2007) Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8:359–368
Leach MW, Bean AG, Mauze S, Coffman RL, Powrie F (1996) Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol 148:1503–1515
Acknowledgement
This work was supported by Senior Research Award #296598 from the Crohn’s and Colitis Foundation of America (to C.B.W.), NIH R01 AI073731 and R01 AI085090 (to C.B.W. and T.A.C.), the D.B. and Marjorie Reinhart Family Foundation (to C.B.W.), and the Children’s Hospital of Wisconsin (to C.B.W.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Haribhai, D., Chatila, T.A., Williams, C.B. (2016). Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease. In: Ivanov, A. (eds) Gastrointestinal Physiology and Diseases. Methods in Molecular Biology, vol 1422. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3603-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3603-8_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3601-4
Online ISBN: 978-1-4939-3603-8
eBook Packages: Springer Protocols